Highlights
NYSE: ACT       Advisorshares Vice ETF
Last Price Today's Change   Day's Range   Trading Volume
24.389   -0.068 (0.28%)  24.23 - 24.62  1,388

Overview

 
Avg Volume (4 weeks):1,930
4 Weeks Range:23.435 - 24.62
4 Weeks Price Volatility (%):
80.51%
52 Weeks Range:20.88 - 26.02
52 Weeks Price Volatility (%):
68.27%
Average Price Target: 340.00
Price Target Upside/Downside: +315.611

Headlines



No recent Headlines for this stock.


Business Background

Actavis plc is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In October 2013, Actavis Inc acquired Warner Chilcott PLC and in connection with the acquisition, Actavis Inc and Warner Chilcott PLC have been combined under a new company, Actavis plc.

  Be the first to like this.
 


 

2954  2614  494  2908 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.827+0.282 
 AMD 37.52+0.81 
 ET 11.16-0.50 
 GE 11.29-0.13 
 AABA 19.630.00 
 DIS 148.72+10.14 
 BAC 32.79-0.30 
 F 8.81-0.23 
 UBER 26.71+0.01 
Partners & Brokers